Skip to content
value.today

Ascent Therapeutics Inc

Total raised
$24 M
2 rounds on record
Latest round
$5 M
Aug 2010
First round on record
Oct 2007
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Ascent Therapeutics Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2010$5 MNo. 2$2 to $10 million

Ascent Therapeutics Inc: Raise no. 2, Aug 2010

Investors in this round

4 investors had bought by the notice of Aug 23, 2010: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $15 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frederick Jones, III, M.D., MBA · Executive Officer, Director
  • Stephen K. Hunt · Executive Officer
  • Thomas K. McMurry · Executive Officer
  • Christopher K. Mirabelli · Director
  • Jnes Eckstein · Director
  • Lauren K. Silverman · Director
  • Michael K. Webb · Director
  • Robert K. Kamen · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frederick Jones III, M.D., MBA, President. Source: SEC Form D, newest notice filed Aug 23, 2010. Read the notice at the SEC.

equitySEC
Oct 2007$19 MNo. 1$10 to $50 million

Ascent Therapeutics Inc: Raise no. 1, Oct 2007

Investors in this round

4 investors had bought by the notice of May 27, 2009: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in De

People named in the notice

  • Frederick Jones · Executive Officer, Director
  • Stephen Hunt · Executive Officer
  • Thomas McMurry · Executive Officer
  • Athan Kuliopulos · Director
  • Christopher K. Mirabelli · Director
  • Jens Eckstein · Director
  • Lauren Silverman · Director
  • Michael Webb · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frederick Jones III, M.D., M.B.A., President and Chief Executive Officer. Source: SEC Form D, newest notice filed May 27, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Ascent Therapeutics Inc chose not to state its revenue in its newest notice of a funding round (Aug 2010).

    SEC Form D · Aug 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2010

That is all the official record says: Ascent Therapeutics Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Ascent Therapeutics Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Ascent Therapeutics Inc
NameRoleNamed in
Frederick Jones, III, M.D., MBAExecutive officerAug 2010
Stephen K. HuntExecutive officerAug 2010
Thomas K. McMurryExecutive officerAug 2010
Frederick JonesExecutive officerMay 2009
Stephen HuntExecutive officerMay 2009
Thomas McMurryExecutive officerMay 2009
Christopher K. MirabelliDirectorAug 2010
Frederick Jones, III, M.D., MBADirectorAug 2010
Jnes EcksteinDirectorAug 2010
Lauren K. SilvermanDirectorAug 2010
Michael K. WebbDirectorAug 2010
Robert K. KamenDirectorAug 2010
Athan KuliopulosDirectorMay 2009
Frederick JonesDirectorMay 2009
Jens EcksteinDirectorMay 2009
Lauren SilvermanDirectorMay 2009
Michael WebbDirectorMay 2009